HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection.
about
Sex-dependent treatment of chronic EAE with partial MHC class II constructs.Upregulation of CD74 and its potential association with disease severity in subjects with ischemic stroke.miR-155 Dysregulation and Therapeutic Intervention in Multiple Sclerosis.Potential immunotherapies for traumatic brain and spinal cord injury.Targeting NLRP3 Inflammasome in the Treatment of CNS DiseasesMacrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury
P2860
HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
HLA-DRα1-mMOG-35-55 treatment ...... and promotes neuroprotection.
@ast
HLA-DRα1-mMOG-35-55 treatment ...... and promotes neuroprotection.
@en
type
label
HLA-DRα1-mMOG-35-55 treatment ...... and promotes neuroprotection.
@ast
HLA-DRα1-mMOG-35-55 treatment ...... and promotes neuroprotection.
@en
prefLabel
HLA-DRα1-mMOG-35-55 treatment ...... and promotes neuroprotection.
@ast
HLA-DRα1-mMOG-35-55 treatment ...... and promotes neuroprotection.
@en
P2093
P2860
P1476
HLA-DRα1-mMOG-35-55 treatment ...... and promotes neuroprotection.
@en
P2093
Arthur A Vandenbark
Gil Benedek
Halina Offner
Kelley Jordan
Lucy Keenlyside
Roberto Meza-Romero
P2860
P2888
P356
10.1186/S12974-015-0342-4
P577
2015-06-24T00:00:00Z
P5875
P6179
1016716049